810209P

C6-NBD Ceramide

Avanti Research^™ - A Croda Brand

• Sinónimos: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine
• Fórmula empírica (notación de Hill): C₃₀H₄₉N₅O₆
• Número de CAS: 94885-02-6
• Peso molecular: 575.74
• Número MDL: MFCD02259244
• Código UNSPSC: 12352211
• NACRES: NA.25

Propiedades

• Ensayo: >99% (TLC)
• Formulario: powder
• envase: pkg of 1 × 1 mg (810209P-1mg)
• fabricante / nombre comercial: Avanti Research^™ - A Croda Brand
• Condiciones de envío: dry ice
• temp. de almacenamiento: −20°C
• cadena SMILES: [N+](=O)([O-])c1c2n[o]nc2c(cc1)NCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCC)CO
• InChI: 1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
• Clave InChI: HZIRBXILQRLFIK-VPZZKNKNSA-N

Descripción

Descripción general

C6-NBD ceramide is a fluorescent labelled compound, known to be useful for the detection of enzymatic action. C6-NBD ceramide is preferred over radioactive compounds.

Aplicación

C6-NBD Ceramide is suitable as a substrate for sphingomyelin synthase activity assay.

Acciones bioquímicas o fisiológicas

Ceramide is one of the products of sphingolipid metabolism. The members of ceramide synthases family are responsible for its synthesis. Each ceramide synthesized differs in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.

Envase

5 mL Amber Glass Screw Cap Vial (810209P-1mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids